Summary
Conclusion
Human pancreas-specific protein (hPASP) is a very sensitive reflector of the extent of pancreatic necrosis on the cellular level, and is of both diagnostic and prognostic value in acute pancreatitis. Furthermore, it allows the estimation of the severity of graft pancreatitis soon after simultaneous renal and pancreatic transplantation.
Background
Diagnosis of acute pancreatitis (AP) has been improved in the past 15 yr as new methods for the determination of specific pancreatic enzymes have been developed. However, these enzymes have no prognostic implications. In this prospective study, we evaluated the role of human pancreas-specific protein (hPASP) in comparison with pancreatic amylase and C-reactive protein (CRP) in acute pancreatitis and pancreas transplantation.
Patients and Methods
The study included 40 patients (22 female, 18 male; mean age 51 yr, range 22–88 yr) with AP and 7 patients (2 female, 5 male; mean age 37 yr, range 25–49 yr) with type I diabetes and renal insufficiency who underwent simultaneous kidney and pancreas transplantation. By means of contrast-enhanced computed tomography (CT) and/or intraoperative findings, patients were judged to have edematous-interstitial (AIP,n=20, mean age 55.2 yr, range 24–88 yr) or necrotizing pancreatitis (NP,n=20, mean age 46.3 yr, range 22–81 yr). Serum hPASP concentration was measured daily by a commercial radioimmunoassay technique. In 25 healthy subjects and in several control groups (35 patients with chronic pancreatitis, 20 patients with pancreatic carcinoma and 80 patients with different gastrointestinal diseases) a single blood specimen was taken at hospital admission for the determination of the normal range of hPASP and for specificity analysis.
Results
The upper normal value for hPASP in healthy subjects was found to be 52 ng/mL. Serum hPASP was elevated in all patients suffering from AP, with a median of 343 ng/mL (lower-upper quartile: 192–478 ng/mL) at hospital admission. In the daily serum monitoring with respect to the onset of symptoms, significantly higher hPASP levels were found in NP compared with AIP after day 2 (p<0.001). In patients with NP, peak values of hPASP correlated significantly with the extent of pancreatic necroses measured by contrast-enhanced CT-scanning, whereas CRP did not. Six patients of the transplantation group had the same serum hPASP course as AIP, with almost normal values on the third postoperative day. One patient had elevated levels throughout the observation period. This patient suffered from necrotizing graft pancreatitis, confirmed by relaparotomy, and died because of subsequent septic complications.
Similar content being viewed by others
References
Pousette Å, Fernstad R, Sköldefors H, Carlström K. A novel assay for pancreatic cellular damage: I. Characterization of protein profiles in human pancreatic cytosol and purification and characterization of a pancreatic specific protein.Pancreas 1988; 3: 421–426.
Yamamoto K, Pousette Å, Phoebe Ch, et al. Isolation of a cDNA encoding a human serum mariner for acute pancreatitis.J Biol Chem 1992; 267: 2575–2581.
Fernstad R, Pousette Å, Carlström K, Sköldefors H. A novel assay for pancreatic cellular damage: IV. Serum concentrations of pancreas-specific protein (PASP) in acute pancreatitis and other abdominal diseases.Pancreas 1990; 5: 42–49.
Pousette Å, Fernstad R, Sköldefors H, Carlström K. A novel assay for pancreatic cellular damage: II. High tissue specificity of a pancreatic protein.Pancreas 1988; 3: 642–645.
Fernstad R, Sköldefors H, Pousette Å, et al. A novel assay for pancreatic cellular damage: Ill. Use of a pancreas-specific protein as a marker of pancreatic graft dysfunction in humans.Pancreas 1989; 4: 44–52.
Fernstad R, Tydén G, Brattstrom CH, et al. Pancreas-specific: protein: New serum marker for graft rejection in pancreas-transplant recipients.Diabetes 1989; 38: 55, 56.
Nordestgaard AG, Wilson SE, Russell AW. Correlation of serum amylase levels with pancreatic pathology and pancreatitis etiology.Pancreas 1988; 2: 159–162.
Spechler SJ, Schimmel EH. Serum amylase in pancreatitis.Dig Dis Sci 1985; 30: 92, 93.
Uhl W, Malfertheiner P, Drosdat H, Martini M, Büchler M. Determination of pancreatic lipase by immunoactivation technology.Int J Pancreatol 1992; 3: 253–261.
Chen CC, Wang SS, Chao Y, Lu CW, Lee SD, Tsai YT, Lo KJ. C-reactive protein and lactat dehydrogenase isoenzymes in the assessment of prognosis of acute pancreatitis.J Gastroenterol Hepatol 1992; 4: 363–366.
Mayer AD, McMahon M, Bowen MJ, Cooper EH. C-reactive protein: an aid to assessment and monitoring of acute pancreatitis.J Clin Path 1984; 37: 207–211.
Block S, Maier W, Clausen C, Bittner R, Büchler M, Malfertheiner P, Beger HG. Identification of pancreas necrosis in severe acute pancreatitis: Imaging procedures versus clinical staging.Gut 1986; 27: 1035–1042.
Balthazar EJ. CT diagnosis and staging of acute pancreatitis.Rad Clin North Am 1989; 27: 19–37.
Koop H. Serum levels of pancreatic enzymes and their clinical significance, inThe Exocrine Pancreas, Clinics in Gastroenterology, Creutzfeld W (ed.), W. B. Saunders, London, Philadelphia, Toronto, 1984; pp. 739–762.
Steinberg WM. Predictors of severity of acute pancreatitis.Gastroenterol Clin North Am 1990; 19: 849–861.
Büchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis: results of a prospective study.Int J Pancreatol 1986; 1: 227–235.
Büchler M. Objectivation of the severity of acute pancreatitis.Hepato-Gastroenterol 1991; 38: 101–108.
Isenmann R, Büchler MW, Uhl W, Malfertheiner P, Martini M, Beger HG. Pancreatic necrosis: an early finding in severe acute pancreatitis.Pancreas 1993; 8: 358–361.
Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG. PMN-Elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis.Pancreas 1991; 6: 253–259.
Nyberg G, Olausson M, Nordén G, et al. Pancreas-specific protein: Monitoring in pancreas transplantation.Transplant Proc 1991; 23: 1604, 1605.
Fernstad R, Kylander Ch, Tsai L, Tydén G, Pousette Å. Isoforms of procarboxypeptidase B (pancreas-specific protein, PASP) in human serum, pancreatic tissue and juice.Scand J Clin Lab Invest 1993; 53: 9–17.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmid, S.W., Uhl, W., Steinle, A. et al. Human pancreas-specific protein. Int J Pancreatol 19, 165–170 (1996). https://doi.org/10.1007/BF02787364
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02787364